
Bio-Rad Delivers Strong Q3 2025 Results
Bio‑Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a prominent global provider of life-science research and clinical diagnostics instruments and consumables, has today reported its financial performance for the third quarter ended September 30, 2025. In the face of challenging market…












